Article ID: 715850

A highly competitive $4.5 million grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) will support Keck School of Medicine of USC efforts to recruit patients from underrepresented populations into cardiac surgery clinical trials.

Article ID: 715853

In 1976, Joel Geiderman, MD, decided he would take a leap of faith and specialize in a new area of medicine: emergency medicine. Now the co-chair of Cedars-Sinai's Ruth and Harry Roman Emergency Department discusses the transformative growth that has occurred in the specialty during the 40 years since it was officially established as a distinct area of patient care.

Article ID: 715828

The first-of-its-kind study asked people with mental health disorders to recommend changes to international diagnostic guidelines

Article ID: 715634

Scientists created human pancreas on a chip that allowed them to identify the possible cause of a frequent and deadly complication of cystic fibrosis (CF) called CF-Related Diabetes, or CFRD. It may be feasible to also use the small two-chambered device, which features bioengineered human pancreatic organoids to study the causes of non-CF-related conditions such as type 1 and 2 diabetes, according to researchers who report findings in Nature Communications.

Article ID: 715826

Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a high-level overview of machine learning for healthcare outcomes researchers and decision makers.

Article ID: 715851

Eye research funders come together to foster research to treat age-related macular degeneration.

Article ID: 715844

Article ID: 715848

A new study of cabbage crops in New York – a state industry worth close to $60 million in 2017, according to the USDA – reports for the first time that the effectiveness of releasing natural enemies to combat pests depends on the landscape surrounding the field.

Article ID: 715810

A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.